Genmab A/S (GMAB)
28.15
+0.69
(+2.51%)
USD |
NASDAQ |
Apr 26, 16:00
28.13
-0.02
(-0.07%)
After-Hours: 20:00
Genmab Gross Profit Margin (Quarterly): 97.31% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 97.31% |
September 30, 2023 | 97.89% |
June 30, 2023 | |
March 31, 2023 | |
December 31, 2022 | |
September 30, 2022 | |
June 30, 2022 | |
March 31, 2022 | |
December 31, 2021 | |
September 30, 2021 | |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 |
Date | Value |
---|---|
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
97.31%
Minimum
Dec 2023
97.89%
Maximum
Sep 2023
97.60%
Average
97.60%
Median
Gross Profit Margin (Quarterly) Benchmarks
Ascendis Pharma A/S | 85.87% |
Novo Nordisk A/S | 84.80% |
Galecto Inc | -- |
Evaxion Biotech AS | -- |
IO Biotech Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | 14.96% |
Return on Assets | 13.39% |
Return on Invested Capital | 14.96% |
Profit Margin (Quarterly) | 13.68% |
Operating Margin (Quarterly) | 35.70% |
Return on Net Operating Assets | 65.38% |